XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation
3 Months Ended
Nov. 30, 2017
Share-Based Compensation

Note 11 – Share-Based Compensation



The Company’s current share-based compensation plans, approved by the stockholders of the Company, provides for awards of stock options, restricted shares, restricted stock units, stock appreciation rights, performance shares, and performance stock units to employees and non-employee directors of the Company.  The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors based on estimated fair values. Share-based compensation expense was $1.0 million and $0.9 million for the three months ended November 30, 2017 and November 30, 2016, respectively.













The following table illustrates the type and fair value of the share-based compensation awards granted during the three month periods ended November 30, 2017 and November 30, 2016:







 

 

 

 

 

 

 

 

 



Three months ended November 30,



2017

 

2016



Number of units granted

 

Weighted average grant-date
fair value per award

 

Number of units granted

 

Weighted average grant-date
fair value per award

Stock options

44,312 

 

$

30.73 

 

47,223 

 

$

26.25 

RSUs

69,198 

 

$

87.06 

 

37,033 

 

$

74.80 

PSUs

14,854 

 

$

88.06 

 

15,902 

 

$

74.80 





The RSUs granted during the three months ended November 30, 2017 and November 30, 2016 consisted of 3,980 and 3,634, respectively, of awards that will be settled in cash. The weighted average stock price on the date of the grant was $91.56 and $78.23 for 2017 and 2016, respectively.



The following table provides the assumptions used in determining the fair value of the stock options awarded during the three month periods ended November 30, 2017 and November 30, 2016:

















 

 

 



Grant Year



2017

 

2016

Weighted-average dividend yield

1.3% 

 

1.5% 

Weighted-average volatility

34.0% 

 

36.5% 

Range of risk-free interest rates

2.2% 

 

1.5% 

Weighted-average expected lives

7 years

 

7 years